361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo

N. E. Fullerton; M. Boyd; R.J. Mairs; S. Ross; L. Wilson; J. Dorrens; N. Keith; D. Kirk

doi:10.1016/S1569-9056(04)90360-0

361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo

N. E. Fullerton, M. Boyd, R.J. Mairs, S. Ross, L. Wilson, J. Dorrens, N. Keith, D. Kirk

Research output: Contribution to journal › Conference abstract › peer-review

Original language	English
Pages (from-to)	93
Number of pages	1
Journal	European Urology Supplements
Volume	3
Issue number	2
DOIs	https://doi.org/10.1016/S1569-9056(04)90360-0
Publication status	Published - 1 Feb 2004

Keywords

prostate cancer
radiopharmceuticals

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1569-9056(04)90360-0

Cite this

Fullerton, N. E., Boyd, M., Mairs, R. J., Ross, S., Wilson, L., Dorrens, J., Keith, N., & Kirk, D. (2004). 361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo. European Urology Supplements, 3(2), 93. https://doi.org/10.1016/S1569-9056(04)90360-0

@article{dae2677809de4a8492377776505d392c,

title = "361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo",

keywords = "prostate cancer, radiopharmceuticals",

author = "Fullerton, \{N. E.\} and M. Boyd and R.J. Mairs and S. Ross and L. Wilson and J. Dorrens and N. Keith and D. Kirk",

year = "2004",

month = feb,

day = "1",

doi = "10.1016/S1569-9056(04)90360-0",

language = "English",

volume = "3",

pages = "93",

journal = "European Urology Supplements",

issn = "1569-9056",

number = "2",

}

Fullerton, NE, Boyd, M, Mairs, RJ, Ross, S, Wilson, L, Dorrens, J, Keith, N & Kirk, D 2004, '361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo', European Urology Supplements, vol. 3, no. 2, pp. 93. https://doi.org/10.1016/S1569-9056(04)90360-0

361 Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo. / Fullerton, N. E.; Boyd, M.; Mairs, R.J. et al.
In: European Urology Supplements, Vol. 3, No. 2, 01.02.2004, p. 93.

Research output: Contribution to journal › Conference abstract › peer-review

TY - JOUR

T1 - 361 Targeted radiotherapy and gene therapy for prostate cancer

T2 - transfection of the noradrenaline transporter gene under the control of telomerase promoters; in vitro and in vivo

AU - Fullerton, N. E.

AU - Boyd, M.

AU - Mairs, R.J.

AU - Ross, S.

AU - Wilson, L.

AU - Dorrens, J.

AU - Keith, N.

AU - Kirk, D.

PY - 2004/2/1

Y1 - 2004/2/1

KW - prostate cancer

KW - radiopharmceuticals

U2 - 10.1016/S1569-9056(04)90360-0

DO - 10.1016/S1569-9056(04)90360-0

M3 - Conference abstract

SN - 1569-9056

VL - 3

SP - 93

JO - European Urology Supplements

JF - European Urology Supplements

IS - 2

ER -